COVID-19: Caring for Patients and Communities
At Providence Sacred Heart Medical Center in Spokane, Washington, we were involved very early in this pandemic. We are still caring for the majority of patients with the coronavirus in our community, and we learn more every day. Looking back on many months of dealing with COVID-19, here are some…
The spread of COVID-19 revealed systemic cracks in the social needs and public health infrastructure of communities — inequities that have existed for decades. A Kaiser Permanente survey of 2,900 of its members earlier this year illustrates the disproportionate impact the pandemic is having on the…
An AHA Member Call on Allocation and Distribution of Operation Warp Speed (OWS) Therapeutics with Nancy Foster and John Redd, MD, CMO, ASPR, including remdesivir and monoclonal antibody (MAB) therapeutics like bamlanivimab through the Emergency Use Authorization (EUA).
The AHA will host a call today, Nov. 16, from 4-5 p.m. ET with leaders from the Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) and other federal agencies to discuss the delivery and administration of monoclonal antibody therapies.
The AHA will host a call on Monday, Nov. 16, from 4-5 p.m. ET with leaders from the Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) and other federal agencies to discuss the delivery and administration of monoclonal antibody therapies…
The Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response has released guidance on considerations for health care providers exploring high-flow nasal cannula therapy, a less-invasive oxygen therapy than mechanical ventilation that has shown…
The Food and Drug Administration Nov. 10 issued an emergency use authorization (EUA) for Eli Lilly and Company’s monoclonal antibody therapy, bamlanivimab. The EUA authorizes the product’s use, but only in outpatient settings; additionally, it sets forth the type of patients eligible to receive the…
In a study of 106,543 patients hospitalized for COVID-19 between March and July, 9% were readmitted to the same hospital within two months of discharge, the Centers Disease Control and Prevention reported.
Existing hospital or community based infusion centers
Existing clinical space (e.g. urgent care, emergency depts)
Ad hoc new infusion sites (e.g. "hospitals without walls”)
Initial version of playbook focused on:
The Centers for Medicare & Medicaid Services launched the Nursing Home Resource Center to provide the latest COVID-19 information, guidance and data. CMS said the centralized hub includes resources for clinicians, including facility inspection reports, training and payment policy information.